BELLUS Health

News
Events & Presentations

Visit us on twitter
Visit us on linkedin

About Us
Pipeline
- Our Pipeline
- Camlipixant (BLU-5937)
Science
- Role of P2X3
- Scientific Publications
Patients
- What is Chronic Cough?
- Clinical Trials
Investors & Media
Careers
- Join Our Team
- Job Opportunities

INVESTOR
CONTACT

Ramzi Benamar
Chief Financial Officer
ir@bellushealth.com

Name

Email

Subject

Comments

Leave this field blank

Investors Home
Press Releases
Events & Presentations
Financial Reports & Other
- SEC Filings
- Other Filings
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Corporate Governance
Investor Resources

BELLUS Health, Inc.

275 Armand-Frappier Blvd.
Laval, Quebec
Canada H7V 4A7

T 450 680 4500

F 450 680 4501

E info@bellushealth.com

Visit us on twitter
Visit us on linkedin

BELLUS HEALTH IS A DRUG DEVELOPMENT COMPANY AND OUR PRODUCT CANDIDATES ARE NOT YET COMMERCIALIZED. INVESTING IN OUR COMMON SHARES INVOLVES A SIGNIFICANT AMOUNT OF RISK. REFER TO THE ANNUAL INFORMATION FORM IN THE INVESTOR AND MEDIA SECTION OF THIS WEBSITE OR AT WWW.SEDAR.COM FOR A DESCRIPTION OF RISKS FACTORS ASSOCIATED WITH OUR BUSINESS.

Risk Factors
Privacy Notice
Legal Disclaimer
Site Map